IDSA GUIDELINES Bundle (free trial)

Drug-Susceptible Tuberculosis

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/770889

Contents of this Issue

Navigation

Page 13 of 23

14 Treatment Figure 2. Baseline And Follow-Up Evaluations For Patients Treated With First-Line Tuberculosis Medications Month of Treatment Completed Activity Baseline 1 2 3 4 5 6 7 8 End of Treatment Visit Microbiology Sputum smears and culture 1 ❑ ❑ ❑ ❑ ❑ ❑ Drug susceptibility testing 2 ❑ ❑ Imaging Chest radiograph or other imaging 3 ❑ ❑ ❑ Clinical Assessment Weight 4 ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ Symptom and adherence review 5 ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ Vision assessment 6 ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ Laboratory Testing AST, ALT, bilirubin, alkaline phosphate 7 ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ Platelet count 8 ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ Creatinine 8 ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ HIV 9 ❑ Hepatits B and C screen 10 ❑ Diabetes screen 11 ❑

Articles in this issue

Archives of this issue

view archives of IDSA GUIDELINES Bundle (free trial) - Drug-Susceptible Tuberculosis